News and Analysis

Pendulum Therapeutics fetches $54m Series C

Pendulum Therapeutics, a biotech company targeting the microbiome, has secured $54 million in Series C funding.

-

Pendulum Therapeutics, a biotech company targeting the microbiome, has secured $54 million in Series C funding. Meritech Capital led the round with participation from existing investors including Sequoia Capital, True Ventures and Khosla Ventures.

Source: Press Release